S. Jahns, P. Glorius, M. Hansen, Y. Nazirizadeh, M. Gerken
{"title":"Imaging label-free biosensor with microfluidic system","authors":"S. Jahns, P. Glorius, M. Hansen, Y. Nazirizadeh, M. Gerken","doi":"10.1117/12.2179366","DOIUrl":null,"url":null,"abstract":"We present a microfluidic system suitable for parallel label-free detection of several biomarkers utilizing a compact imaging measurement system. The microfluidic system contains a filter unit to separate the plasma from human blood and a functionalized, photonic crystal slab sensor chip. The nanostructure of the photonic crystal slab sensor chip is fabricated by nanoimprint lithography of a period grating surface into a photoresist and subsequent deposition of a TiO2 layer. Photonic crystal slabs are slab waveguides supporting quasi-guided modes coupling to far-field radiation, which are sensitive to refractive index changes due to biomarker binding on the functionalized surface. In our imaging read-out system the resulting resonance shift of the quasi-guided mode in the transmission spectrum is converted into an intensity change detectable with a simple camera. By continuously taking photographs of the sensor surface local intensity changes are observed revealing the binding kinetics of the biomarker to its specific target. Data from two distinct measurement fields are used for evaluation. For testing the sensor chip, 1 μM biotin as well as 1 μM recombinant human CD40 ligand were immobilized in spotsvia amin coupling to the sensor surface. Each binding experiment was performed with 250 nM streptavidin and 90 nM CD40 ligand antibody dissolved in phosphate buffered saline. In the next test series, a functionalized sensor chip was bonded onto a 15 mm x 15 mm opening of the 75 mm x 25 mm x 2 mm microfluidic system. We demonstrate the functionality of the microfluidic system for filtering human blood such that only blood plasma was transported to the sensor chip. The results of first binding experiments in buffer with this test chip will be presented.","PeriodicalId":232941,"journal":{"name":"Microtechnologies for the New Millennium","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microtechnologies for the New Millennium","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1117/12.2179366","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
We present a microfluidic system suitable for parallel label-free detection of several biomarkers utilizing a compact imaging measurement system. The microfluidic system contains a filter unit to separate the plasma from human blood and a functionalized, photonic crystal slab sensor chip. The nanostructure of the photonic crystal slab sensor chip is fabricated by nanoimprint lithography of a period grating surface into a photoresist and subsequent deposition of a TiO2 layer. Photonic crystal slabs are slab waveguides supporting quasi-guided modes coupling to far-field radiation, which are sensitive to refractive index changes due to biomarker binding on the functionalized surface. In our imaging read-out system the resulting resonance shift of the quasi-guided mode in the transmission spectrum is converted into an intensity change detectable with a simple camera. By continuously taking photographs of the sensor surface local intensity changes are observed revealing the binding kinetics of the biomarker to its specific target. Data from two distinct measurement fields are used for evaluation. For testing the sensor chip, 1 μM biotin as well as 1 μM recombinant human CD40 ligand were immobilized in spotsvia amin coupling to the sensor surface. Each binding experiment was performed with 250 nM streptavidin and 90 nM CD40 ligand antibody dissolved in phosphate buffered saline. In the next test series, a functionalized sensor chip was bonded onto a 15 mm x 15 mm opening of the 75 mm x 25 mm x 2 mm microfluidic system. We demonstrate the functionality of the microfluidic system for filtering human blood such that only blood plasma was transported to the sensor chip. The results of first binding experiments in buffer with this test chip will be presented.
我们提出了一种微流控系统,适用于利用紧凑的成像测量系统对几种生物标志物进行平行无标记检测。该微流体系统包含一个过滤单元,用于从人体血液中分离血浆和一个功能化的光子晶体板传感器芯片。光子晶体板传感器芯片的纳米结构是通过将周期光栅表面的纳米压印光刻制成光刻胶并随后沉积TiO2层来制备的。光子晶体板是一种支持准引导模式耦合远场辐射的平板波导,它对生物标记物在功能化表面的结合引起的折射率变化非常敏感。在我们的成像读出系统中,透射光谱中准制导模式的共振位移被转换成一个简单的相机可以检测到的强度变化。通过连续拍摄传感器表面的照片,观察到局部强度变化,揭示了生物标志物与其特定靶标的结合动力学。来自两个不同测量领域的数据用于评估。为了测试传感器芯片,将1 μM生物素和1 μM重组人CD40配体通过amin偶联固定在传感器表面。每次结合实验用250 nM链亲和素和90 nM CD40配体抗体溶解在磷酸盐缓冲盐水中。在接下来的测试系列中,将功能化传感器芯片粘接在75mm x 25mm x 2mm微流控系统的15mm x 15mm开口上。我们展示了微流控系统过滤人体血液的功能,这样只有血浆被输送到传感器芯片。本文将介绍该芯片在缓冲液中的首次结合实验结果。